Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-06-01 @ 8:35 PM
Study NCT ID:
NCT01095302
Status:
COMPLETED
Last Update Posted:
2013-10-16
First Post:
2010-03-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TCD11089
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None